Blacks, Hispanics, older people not benefitting equally from better colon cancer treatment

February 14, 2014

While new and better treatments have improved the odds of survival for patients diagnosed late stage colorectal cancer, that progress has been largely confined to non-Hispanic whites and Asians and those under age 65, according to a new study. American Cancer Society researchers led by Helmneh Sineshaw, M.D., MPH, find there have been no significant increases in survival rates for Hispanics and non-Hispanic blacks with metastatic colon cancer. The study, appearing in the January issue of Cancer Causes and Control, concludes that the findings underscore the need for concerted efforts to increase access to new treatments for minority groups and older patients, as well as a better understanding of the factors contributing to the disparities in survival.

For their study, researchers analyzed data from the 13 population-based cancer registries of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program, which covers about 14 percent of the United States population. They looked at improvement for across major ethnic groups and two broad age ranges (20-64 and over 65 years). Just fewer than 50,000 patients (49,893) were included in the analysis.

The analysis found overall five-year increased significantly between 1992/1997 and 2004/2009 for non-Hispanic whites (9.8% to 15.7%) and for Asians (11.4% 17.7%). The increases were not statistically significant for non-Hispanic blacks (8.6% to 9.8%) or Hispanics (14.0% to 16.4%). And while survival rates increased significantly for those 65 and over for non-Hispanic whites, those increases were much smaller than the increase among those ages 20 to 64.

The authors conclude that increases in survival from metastatic , presumably from improvements in treatment, has been largely confined to younger non-Hispanic whites and Asians, and that there has been no statistically significant increase in survival for non-Hispanic blacks and Hispanics.

"We know from previous studies that when people of any race get equal care they have similar outcomes," said Dr. Sineshaw. "But studies show there are significant inequalities in the dissemination of new treatments, likely leading to the gaps in survival our analysis found. The reasons why ethnic minorities are not getting equal treatment are complicated, but likely include poorer health coming into the system and lower socioeconomic status, which clearly leads to barriers to good health care. Those same factors likely lead to less aggressive treatment for older patients, as well."

"Studies like this tell us what happens when not everyone is given the best care available," said Richard C. Wender, M.D., chief control officer of the American Cancer Society. "We need a concerted effort to make sure all Americans, regardless of skin color, age, or socioeconomic status, reap the lifesaving benefits of better care."

Explore further: Blacks have less access to cancer specialists, treatment

More information: H Sineshaw, A Robbins, A Jemal. Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States, [published online ahead of print DATE, Cancer Causes and Control (DOI: 10.1007/s10552-014-0344-z).

Related Stories

Blacks have less access to cancer specialists, treatment

November 19, 2013
Researchers at the University of California, San Diego School of Medicine say metastatic colorectal cancer patients of African-American descent are less likely to be seen by cancer specialists or receive cancer treatments. ...

Hispanic lung cancer patients tend to live longer than blacks and whites

April 23, 2012
A new analysis has found that Hispanic lung cancer patients seem to live longer than white or black patients. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that, ...

Racial / ethnic differences in CHD outcomes not due to statins

February 7, 2014
(HealthDay)—For hospitalized patients with coronary heart disease (CHD), racial and ethnic differences in one-year outcomes are due to demographics and comorbidity, not differential statin prescriptions, according to a ...

Hispanics live longest, whites shortest among dialysis patients

March 28, 2013
Among kidney failure patients on dialysis, Hispanics tend to live the longest and Whites the shortest, with Blacks' survival time in between these two, according to a study appearing in an upcoming issue of the Clinical Journal ...

Minorities and poor have more advanced thyroid cancers when diagnosed, study shows

January 9, 2014
UCLA researchers have found that minority patients and those of lower socioeconomic status are far more likely to have advanced thyroid cancer when they are diagnosed with the disease than white patients and those in higher ...

Cancer biggest killer of Hispanic Texans

September 30, 2013
More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.